Drug intelligence / Profile preview

Mianyi No.2

Development stage: Unknown
Modality: Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration: Oral

Overview

Mianyi No.2 is a traditional Chinese medicine formula developed for the management of symptoms and signs in HIV/AIDS patients with insufficient immune reconstitution. The formulation is used as an adjunct therapy to improve immune function in these patients, particularly those who do not achieve adequate immune recovery despite antiretroviral therapy[5]. The mechanism of action is not fully elucidated but is believed to involve immunomodulatory effects typical of multi-herbal traditional Chinese medicine formulas.

Brand names: Mianyi No.2
Other names: Mianyi No.2

Beyond the preview

Go deeper on Mianyi No.2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mianyi No.2.

Explore the full profile